The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
Open accessAbstract
BACKGROUND: Cannabis is purported to alleviate symptoms related to cancer treatment, although the patterns of use among cancer patients are not well known. This study was designed to determine the prevalence and methods of use among cancer patients, the perceived benefits, and the sources of information in a state with legalized cannabis. METHODS: A cross‐sectional, anonymous survey of adult cancer patients was performed at a National Cancer Institute–designated cancer center in Washington State. Random urine samples for tetrahydrocannabinol provided survey validation. RESULTS: Nine hundred twenty‐six of 2737 eligible patients (34%) completed the survey, and the median age was 58 years (interquartile range [IQR], 46‐66 years). Most had a strong interest in learning about cannabis during treatment (6 on a 1‐10 scale; IQR, 3‐10) and wanted information from cancer providers (677 of 911 [74%]). Previous use was common (607 of 926 [66%]); 24% (222 of 926) used cannabis in the last year, and 21% (192 of 926) used cannabis in the last month. Random urine samples found similar percentages of users who reported weekly use (27 of 193 [14%] vs 164 of 926 [18%]). Active users inhaled (153 of 220 [70%]) or consumed edibles (154 of 220 [70%]); 89 (40%) used both modalities. Cannabis was used primarily for physical (165 of 219 [75%]) and neuropsychiatric symptoms (139 of 219 [63%]). Legalization significantly increased the likelihood of use in more than half of the respondents. CONCLUSIONS: This study of cancer patients in a state with legalized cannabis found high rates of active use across broad subgroups, and legalization was reported to be important in patients' decision to use. Cancer patients desire but are not receiving information about cannabis use during their treatment from oncology providers. Cancer 2017;123:4488‐97. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735
Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs
(2008) · National Academies Press eBooks · doi:10.17226/11993 · Cited by 708
Cancer care for the whole patient: meeting psychosocial health needs
(2009) · Choice Reviews Online · doi:10.5860/choice.46-3276 · Cited by 574
Hill, K. P. (2015) · JAMA · doi:10.1001/jama.2015.6199 · Cited by 508
Azofeifa, A., Mattson, M. E., Schauer, G., McAfee, T., Grant, A., & Lyerla, R. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6511a1 · Cited by 461
Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.03.002 · Cited by 412
Berman, J. S., Symonds, C., & Birch, R. (2004) · Pain · doi:10.1016/j.pain.2004.09.013 · Cited by 362
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.12.010 · Cited by 327 · cited 1×
“(%) Elementary school 5 (1) High school/GED 102 (11) Some college 252 (28) College graduate 325 (36) Graduate degree 209 (23) Distance from center, median (IQR), miles 25 (10-60) Distance from center, No.”
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324 · cited 3×
“1-3 (no change) 65 (30) 177 (47) 213 (69)”
BackgroundLow-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.10.009 · Cited by 314
Lucas, P., & Walsh, Z. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.01.011 · Cited by 271
Therapeutic aspects of cannabis and cannabinoids
Robson, P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.107 · Cited by 265
Han, B. H., Sherman, S., Mauro, P. M., Martins, S. S., Rotenberg, J., & Palamar, J. J. (2017) · Addiction · doi:10.1111/add.13670 · Cited by 249
Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-2015
Wang, G. S., Le Lait, M.-C., Deakyne, S. J., Bronstein, A. C., Bajaj, L., & Roosevelt, G. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.0971 · Cited by 227
MACHADO ROCHA, F. C., STÉFANO, S. C., DE CÁSSIA HAIEK, R., ROSA OLIVEIRA, L. M. Q., & DA SILVEIRA, D. X. (2008) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.00917.x · Cited by 223
Abrams, D., & Guzman, M. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.108 · Cited by 219
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States
Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1584-6 · Cited by 219
Meiri, E., Jhangiani, H., Vredenburgh, J. J., Barbato, L. M., Carter, F. J., Yang, H.-M., & Baranowski, V. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x167525 · Cited by 214
Lin, L. A., Ilgen, M. A., Jannausch, M., & Bohnert, K. M. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.05.015 · Cited by 195
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products
Anderson, G. D., & Chan, L. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0400-9 · Cited by 156
Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient
Hamadeh, R., Ardehali, A., Locksley, R. M., & York, M. K. (1988) · Chest · doi:10.1378/chest.94.2.432 · Cited by 151 · cited 2×
“General Age, median (IQR), y 58 (46-66) Age by decade, No.”
BackgroundIn the weeds: a baseline view of cannabis use among legalizing states and their neighbours
Pacula, R. L., Jacobson, M., & Hernandez, E. J. M. (2015) · Addiction · doi:10.1111/add.13282 · Cited by 149
Kramer, J. L. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21260 · Cited by 146
Salas‐Wright, C. P., Vaughn, M. G., Cummings‐Vaughn, L. A., Holzer, K. J., Nelson, E. J., AbiNader, M. A., & Oh, S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.031 · Cited by 140
Use of Marijuana for Medical Purposes Among Adults in the United States
Compton, W. M., Han, B., Hughes, A., Jones, C. M., & Blanco, C. (2016) · JAMA · doi:10.1001/jama.2016.18900 · Cited by 130
Medicinal and Recreational Marijuana Use by Patients Infected with HIV
Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S. L., & Bendayan, R. (2004) · AIDS Patient Care and STDs · doi:10.1089/108729104323038892 · Cited by 127
Berman, J. S., Lee, J., Cooper, M., Cannon, A., Sach, J., McKerral, S., Taggart, M., Symonds, C., Fishe, K., & Birch, R. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03408_3.x · Cited by 122
A Systematic Review of the Respiratory Effects of Inhalational Marijuana
Martinasek, M. P., McGrogan, J. B., & Maysonet, A. (2016) · Respiratory Care · doi:10.4187/respcare.04846 · Cited by 121
Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases
Jouanjus, É., Leymarie, F., Tubery, M., & Lapeyre‐Mestre, M. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03897.x · Cited by 111
Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.
Doblin, R., & Kleiman, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1314 · Cited by 108
Recent Trends in the Prevalence of Marijuana Use and Associated Disorders in the United States
Grucza, R. A., Arpana Agrawal, A., Krauss, M. J., Cavazos‐Rehg, P. A., & Bierut, L. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3111 · Cited by 107
Cannabis use in patients with multiple sclerosis
Chong, M. S., Wolff, K., Wise, K., Tanton, C., WINSTOCK, A. R., & Silber, E. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070947 · Cited by 105
Characterization of edible marijuana product exposures reported to United States poison centers
Cao, D. J., Srisuma, S., Bronstein, A. C., & Hoyte, C. O. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1209761 · Cited by 103
Fungal Contamination of Tobacco and Marijuana
Verweij, P. E., Kerremans, J. J., Voss, A., & Meis, J. F. G. M. (2000) · JAMA · doi:10.1001/jama.284.22.2875 · Cited by 101
Medical Marijuana Use in Oncology: A Review
Wilkie, G., Sakr, B. J., & Rizack, T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0155 · Cited by 97
Szyper‐Kravitz, M., Lang, R., Manor, Y., & Lahav, M. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097776 · Cited by 92
Marijuana use trajectories during the post-college transition: Health outcomes in young adulthood
Caldeira, K. M., O’Grady, K. E., Vincent, K. B., & Arria, A. M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.02.022 · Cited by 91
A User’s Guide to Cannabinoid Therapies in Oncology
Maida, V., & Daeninck, P. J. (2016) · Current Oncology · doi:10.3747/co.23.3487 · Cited by 90
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
Waissengrin, B., Urban, D., Leshem, Y., Garty, M., & Wolf, I. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.05.018 · Cited by 88
A microbiome assessment of medical marijuana
Thompson, G. R., Tuscano, J. M., Dennis, M., Singapuri, A., Libertini, S. J., Gaudino, R., Torres, A., Delisle, J., Gillece, J. D., Schupp, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.12.001 · Cited by 88
Fungal Contamination of Tobacco and Marijuana
Verweij, P. E. (2000) · JAMA · doi:10.1001/jama.284.22.2869 · Cited by 86
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
Weiss, A., & Friedenberg, F. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.035 · Cited by 86
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
Hazekamp, A., & Heerdink, E. R. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1503-y · Cited by 82
Côté, M., Trudel, M., Wang, C., & Fortin, A. (2015) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489415612801 · Cited by 80
Prevalence of medical marijuana use in C alifornia, 2012
Ryan‐Ibarra, S., Induni, M., & Ewing, D. (2014) · Drug and Alcohol Review · doi:10.1111/dar.12207 · Cited by 79
The Use of Medical Marijuana in Cancer
Birdsall, S., Birdsall, T. C., & Tims, L. A. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0530-0 · Cited by 79
Marijuana Tourism and Emergency Department Visits in Colorado
Kim, H. S., Hall, K. E., Genco, E. K., Dyke, M. V. V., Barker, E. R., & Monte, A. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1515009 · Cited by 76
Impact of Changes in Regular Use of Marijuana and/or Tobacco On Chronic Bronchitis
Tashkin, D. P., Simmons, M. S., & Tseng, C. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.671868 · Cited by 64
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana
Hauser, N., Sahai, T., Richards, R. J., & Roberts, T. (2016) · Case Reports in Transplantation · doi:10.1155/2016/4028492 · Cited by 52
DiNitto, D. M., & Choi, N. G. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210002176 · Cited by 49
Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence
Self, T. H., Shah, S. P., March, K. L., & Sands, C. W. (2016) · Journal of Asthma · doi:10.1080/02770903.2016.1259420 · Cited by 45
Luckett, T., Phillips, J. L., Lintzeris, N., Allsop, D., Lee, J. T., Solowij, N., Martin, J. H., Lam, L. T.-M., Aggarwal, R., McCaffrey, N., et al. (2016) · Internal Medicine Journal · doi:10.1111/imj.13224 · Cited by 43
Meyer, J. S., & Connor, R. E. (1982) · Cancer · doi:10.1002/1097-0142(19820815)50:4<636::aid-cncr2820500404>3.0.co;2-4 · Cited by 41
Bricker, J. B., Russo, J. E., Stein, M. B., Sherbourne, C. D., Craske, M. G., Schraufnagel, T. J., & Roy‐Byrne, P. (2006) · Depression and Anxiety · doi:10.1002/da.20248 · Cited by 40
CANNABIS AND CANCER CHEMOTHERAPY
Colls, B. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91642-6 · Cited by 15
Sznitman, S. R., Goldberg, V., Sheinman‐Yuffe, H., Flechter, E., & Bar‐Sela, G. (2016) · Cancer · doi:10.1002/cncr.30185 · Cited by 12
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer Beware
Hill, K. P., & Weiss, R. D. (2016) · JAMA · doi:10.1001/jama.2016.5181 · Cited by 10
Marijuana Smoking in Patients with Leukemia
Khwaja, S. I., Yacoub, A. T., Cheema, A., Rihana, N., Russo, R. J., Velez, A. P., Nanjappa, S., Sandin, R. L., Bohra, C., Gajanan, G., et al. (2016) · Cancer Control · doi:10.1177/107327481602300311 · Cited by 7
Cited by
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Metadata
- Authors
- Pergam, S. A., Woodfield, M. C., Lee, C. M., Cheng, G., Baker, K. K., Marquis, S. R., & Fann, J. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-09-25
- Volume
- 123
- Issue
- 22
- Pages
- 4488-4497
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2756837979
- Cited by
- 267
- References
- 62
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.